Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Livingston NJ, New Brunswick NJ, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
for
Renal Transplant Failure and Rejection
Location: Livingston NJ, Worcester MA, Falls Church VA,
Sponsor: Nefro Avillion Clinical Development, LLC
Sex: All
Age: 18 - 70
Code: NCT07508787
Phase2, Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livingston NJ, New York NY, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase2, Recruiting
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: West Orange NJ, Philadelphia PA, Richmond VA,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07219043
Phase2, Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Location: Livingston NJ, Richmond VA, Atlanta GA, Miami FL,
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06798909
Phase3, Recruiting
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Livingston NJ, Wilmington DE, Hershey PA, Boston MA,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Livingston NJ, New York NY, The Bronx NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Livingston NJ, New York NY, Piscataway NJ,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Livingston NJ, New York NY, Paramus NJ, Ridgewood NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livingston NJ, New York NY, Paramus NJ, Ridgewood NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Livingston NJ, New York NY, Paramus NJ, Ridgewood NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Livingston NJ, New Brunswick NJ, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Livingston NJ, New York NY, Paramus NJ, Ridgewood NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Livingston NJ, Summit NJ, New York NY, Brooklyn NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase3, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Livingston NJ, New Brunswick NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase2, Phase3, Recruiting
Non-Invasive Preeclampsia Screening and Biobank
for
Preeclampsia (PE)
Location: Livingston NJ, New York NY, New Brunswick NJ,
Sponsor: Sequenom, Inc.
Sex: Female
Age: 18+
Code: NCT06643741
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: Jersey City NJ, Maspeth NY, Laurelton NY, Newburgh NY,